Factor VIII polypeptides having FVIII:C activity that contain modifications
in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor
VIII, characterized by the binding affinity to low density lipoprotein receptor
protein, and methods for producing the same.